Pay in 4 interest-free payments of $17.50 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
GJ-103 sodium
is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities
InChiKey: WWONFUQGBVOKOF-UHFFFAOYSA-N
without modifying seizures acutely
InChiKey: GEPYBHCJBORHCE-SFHVURJKSA-N
FLI-06 - Notch Pathway Modulator. CAS# 313967-18-9 Catalog No.:M60149-10S GJ-103 sodiumFLI 06, CAS No. 313967 18 9, is a novel potent and selective small molecule intercepting Notch signaling and the early secretory pathway (EC50 ~2. 3 M), identified by using automated microscopy to monitor the trafficking and processing of a ligand independent Notch GFP fusion reporter. FLI 06 can induce accumulation of the reporter at the plasma membrane by interfering with transport in the secretory pathway. It can also disrupt the Golgi apparatus in
US$ 178.00
US$ 104.50
US$ 80.00
US$ 142.00
US$ 21.00
US$ 90.00
US$ 125.00